Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatostatin Plus Clear Liquid Diet vs Diverting Stoma in Rectal Cancer
NCT07605611Recruiting
- Sponsor
- Tongji Hospital
- Start
- Nov 2025
- Primary completion
- Jul 2027
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of somatostatin in anastomotic leak (AL) (2 arms), sponsored by Tongji Hospital. Primary endpoint: Grade C Anastomotic Leakage at 1 month. Started Nov 2025; status: recruiting.
02
Drugs
somatostatin
03
Conditions
anastomotic leak (AL)
Beyond the preview
Go deeper on NCT07605611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07605611.